International Journal of Nanomedicine (Jan 2023)

Incorporation of Targeting Biomolecule Improves Interpolymer Complex-Superparamagnetic Iron Oxide Nanoparticles Attachment to and Activation of T2 MR Signals in M2 Macrophages

  • Nwasike C,
  • Purr E,
  • Nagi JS,
  • Mahler GJ,
  • Doiron AL

Journal volume & issue
Vol. Volume 18
pp. 473 – 487

Abstract

Read online

Chukwuazam Nwasike,1 Erin Purr,1 Jaspreet Singh Nagi,2 Gretchen J Mahler,1 Amber L Doiron2 1Department of Biomedical Engineering, Binghamton University (SUNY), Binghamton, NY, USA; 2Department of Electrical and Biomedical Engineering, University of Vermont, Burlington, VT, USACorrespondence: Amber L Doiron, Email [email protected]: Inflammatory diseases are the leading cause of death in the world, accounting for 3 out of 5 deaths. Despite the abundance of diagnostic tools for detection, most screening and diagnostic methods are indirect and insufficient as they are unable to reliably discriminate between high-risk or low-risk stages of inflammatory diseases. Previously, we showed that the selective activation of interpolymer complexed superparamagnetic iron oxide nanoparticles (IPC-SPIOs) under oxidative conditions can be detected by a change in T2 magnetic resonance (MR) contrast. In this work, IPC-SPIOs were further modified by incorporating mannose as a targeting biomolecule to enhance nanoparticle delivery to M2 macrophages at inflammatory sites.Methods: Uncoated SPIOs were synthesized via coprecipitation from a mixture of FeCl2 and FeCl3, PEGylated by adsorbing PEG 300 kDa (40 mg/mL in water) to SPIOs (3 mg/mL in water) over 24 hours, and complexed by mixing 0.25 mg/mL aqueous poly(gallol) with 2 mg/mL PEG-SPIOs and adding 1 M of phosphate buffer in a 9:9:2 ratio. Mannose-PEG attachment was accomplished conducting a second complexation of mannose-PEG to IPC-SPIOs. M2 macrophages were treated with 150, 100, and 75 μg/mL of IPC-SPIOs and mannose-IPC-SPIOs to investigate activation of T2 MRI signals.Results and Discussion: Surface modification resulted in a slight reduction in ROS scavenging capacity; however, nanoparticle uptake by M2 macrophages increased by over 50%. The higher uptake did not cause a reduction in cellular viability. In fact, mannose-IPC-SPIOs induced significant T2 MR contrast in M2 macrophages compared to IPC-SPIOs and nanoparticles exposed to M1 macrophages. M2 macrophages activated over 30% of mannose-IPC-SPIOs after 6 hours of exposure compared to M1 macrophages and untargeted M2 macrophages. These findings demonstrated that mannose-IPC-SPIOs specifically targeted M2 macrophages and scavenged cellular ROS to activate T2 MR signal, which can be used to detect inflammation.Graphical Abstract: Keywords: targeted nanoparticles, inflammatory diseases, MRI, contrast agents, mannose biomolecules

Keywords